STRO
Sutro Biopharma
14.70$
+1.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.2% | 85.5% | 85.5% | 78.1% | 306.9% | 225.8% | 241.1% | 161.3% | 77.5% | 175.9% | 153.4% | 137.6% | 153.8% | 246.4% | 182.1% | 108.6% | 274.7% | 153.9% | 90.2% | 312.3% | 280.9% | 508.6% | 7.3% | 8.3% | 499.7% | 17.8% | 399.5% | 2.6% | 1.5% | 13.5% | 7.0% | 21.1% | -11.7% | – | 3.0% | 19.6% | 13.9% | 8.8% | – | – | |
| 27.1% | 14.5% | 14.5% | 21.9% | -206.9% | -125.8% | -141.1% | -61.3% | 22.5% | -75.9% | -53.4% | -37.6% | -53.8% | -146.4% | -82.1% | -8.6% | -174.7% | -53.9% | 9.8% | -212.3% | -180.9% | -408.6% | 100.0% | 100.0% | -399.7% | 100.0% | -299.5% | 100.0% | 100.0% | 86.5% | 93.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 91.2% | 100.0% | 97.2% | |
| 72.9% | 85.5% | 85.5% | 78.1% | 374.8% | 225.8% | 241.1% | 161.3% | 77.5% | 175.9% | 153.4% | 137.6% | 153.8% | 246.4% | 182.1% | 108.6% | 274.7% | 153.9% | 90.2% | 312.3% | 280.9% | 508.6% | 115.1% | 126.1% | 499.7% | 310.9% | 399.5% | 269.8% | 47.3% | 437.3% | 241.3% | 729.0% | 479.7% | 296.6% | 60.1% | 411.2% | 314.6% | 251.7% | 322.1% | 316.7% | |
| 24.8% | 24.5% | 24.5% | 28.0% | 100.7% | 76.2% | 70.8% | 68.3% | 39.7% | 89.4% | 76.6% | 66.1% | 76.9% | 121.8% | 91.3% | 50.9% | 125.4% | 75.8% | 44.7% | 194.8% | 148.0% | 255.0% | 53.9% | 58.2% | 170.5% | 122.4% | 144.1% | 90.2% | 14.8% | 97.8% | 48.1% | 168.2% | 61.0% | 76.3% | 16.2% | 90.2% | 74.4% | 52.2% | 79.6% | 71.8% | |
| 97.7% | 24.6% | 24.6% | 106.1% | 475.4% | 302.0% | 311.9% | 229.6% | 117.2% | 265.3% | 230.0% | 203.7% | 76.9% | 121.8% | 91.3% | 50.9% | 125.4% | 75.8% | 44.7% | 194.8% | 148.0% | 255.0% | 169.0% | 184.3% | 170.5% | 433.3% | 144.1% | 360.1% | 62.1% | 521.5% | 282.4% | 897.2% | 540.7% | 493.8% | 105.2% | 599.9% | 389.0% | 295.1% | 403.8% | 407.1% | |
| 2.3% | -10.1% | -10.1% | -6.1% | -375.4% | -202.0% | -211.9% | -129.6% | -17.2% | -165.3% | -130.0% | -103.7% | -130.8% | -268.2% | -173.4% | -59.6% | -300.1% | -129.7% | -35.0% | -407.1% | -328.9% | -663.6% | -69.0% | -84.3% | -570.2% | -333.3% | -443.5% | -260.1% | 37.9% | -435.0% | -189.4% | -797.2% | -440.7% | -393.8% | -5.2% | -499.9% | -289.0% | -203.9% | -303.8% | -309.9% | |
| 1.0% | 2.6% | 5.2% | 1.3% | 9.3% | 6.6% | 8.9% | 6.2% | 2.2% | 13.4% | 11.7% | 9.3% | 7.2% | 14.8% | 31.2% | 13.0% | 27.2% | 5.9% | 3.0% | 9.6% | 5.7% | 11.1% | 2.1% | 11.1% | 8.0% | 23.6% | 32.2% | 51.3% | 7.7% | 72.2% | 35.2% | 92.8% | 58.7% | 61.2% | 15.1% | 107.4% | 88.7% | 65.2% | 100.2% | 87.7% | |
| 2.8% | -9.7% | -9.7% | -8.1% | -379.8% | -207.9% | -202.3% | -130.6% | -7.8% | -165.1% | -131.0% | -105.2% | -130.8% | -274.0% | 315.5% | 96.2% | -719.3% | -207.1% | -21.9% | -362.8% | -357.8% | -663.2% | -83.7% | -77.5% | -400.8% | -391.8% | -368.5% | -280.3% | 41.2% | -447.5% | -186.8% | -572.6% | -473.3% | -436.6% | -18.1% | -586.6% | -402.2% | -265.1% | -391.6% | -395.5% | |
| 0.0% | 0.0% | 0.0% | 0.3% | 12.3% | 0.7% | 0.0% | 4.4% | 0.0% | 13.6% | 10.7% | 7.9% | 7.2% | 9.0% | 31.2% | 13.0% | -27.2% | 5.9% | 3.0% | 9.6% | 5.7% | -0.4% | 8.9% | -6.8% | 29.0% | 3.1% | 1.5% | 10.9% | 13.9% | 13.2% | 0.0% | – | 15.9% | – | 0.0% | – | -0.7% | -0.1% | 0.0% | – | |
| 2.8% | -9.7% | -9.7% | -8.1% | -379.8% | -207.9% | -202.3% | -130.6% | -7.8% | -165.1% | -131.0% | -105.2% | -130.8% | -274.0% | 315.5% | 96.2% | -719.3% | -207.1% | -21.9% | -362.8% | -357.8% | -663.2% | -92.6% | -77.5% | -400.8% | -394.9% | -370.0% | -291.2% | 27.3% | -447.5% | -186.8% | -572.6% | -489.2% | -436.6% | -18.0% | -586.6% | -401.5% | -265.0% | -391.6% | -395.2% | |
| – | -1.5% | -1.5% | 0.1% | -340.9% | -181.3% | -192.2% | -111.1% | -11.2% | -138.5% | -108.0% | -85.9% | -121.3% | -255.5% | -181.2% | -60.3% | -249.4% | -120.9% | -14.9% | -340.1% | -339.8% | -629.6% | -76.6% | -60.7% | -383.1% | -355.5% | -319.7% | -218.8% | 50.4% | -378.8% | -151.5% | -458.7% | -402.0% | -261.9% | 1.7% | -459.6% | -299.6% | -191.1% | -278.6% | -294.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.